Federated Hermes, Inc. Edwards Lifesciences Corp Transaction History

Federated Hermes, Inc.

  • $43 Billion
  • Q4 2024

A detailed history of Federated Hermes, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,136 shares of EW stock, worth $80,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,136
Previous 3,204 64.54%
Holding current value
$80,928
Previous $211,000 60.19%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$64.54 - $75.92 $133,468 - $157,002
-2,068 Reduced 64.54%
1,136 $84,000
Q3 2024

Nov 13, 2024
BUY
$59.7 - $93.78 $94,326 - $148,172
1,580 Added 97.29%
3,204 $211,000
Q2 2024

Aug 08, 2024
SELL
$84.3 - $94.31 $16,944 - $18,956
-201 Reduced 11.01%
1,624 $150,000
Q1 2024

May 14, 2024
SELL
$72.54 - $95.56 $12,912 - $17,009
-178 Reduced 8.89%
1,825 $174,000
Q4 2023

Jan 31, 2024
SELL
$61.71 - $77.76 $647,399 - $815,780
-10,491 Reduced 83.97%
2,003 $152,000
Q3 2023

Nov 13, 2023
SELL
$69.28 - $93.38 $476,577 - $642,361
-6,879 Reduced 35.51%
12,494 $865,000
Q2 2023

Aug 14, 2023
BUY
$81.41 - $94.33 $527,943 - $611,730
6,485 Added 50.32%
19,373 $1.83 Million
Q1 2023

May 08, 2023
BUY
$74.26 - $84.51 $669,528 - $761,942
9,016 Added 232.85%
12,888 $1.07 Million
Q4 2022

Feb 13, 2023
SELL
$68.3 - $87.44 $50.6 Million - $64.8 Million
-740,680 Reduced 99.48%
3,872 $288,000
Q3 2022

Nov 14, 2022
BUY
$82.37 - $107.29 $85,747 - $111,688
1,041 Added 0.14%
744,552 $61.5 Million
Q2 2022

Aug 15, 2022
SELL
$86.5 - $128.27 $4.9 Million - $7.26 Million
-56,616 Reduced 7.08%
743,511 $70.7 Million
Q1 2022

May 13, 2022
SELL
$101.96 - $128.34 $2.53 Million - $3.18 Million
-24,807 Reduced 3.01%
800,127 $94.2 Million
Q4 2021

Feb 14, 2022
BUY
$106.37 - $130.68 $92,116 - $113,168
866 Added 0.11%
824,934 $107 Million
Q3 2021

Nov 15, 2021
BUY
$102.91 - $122.75 $167,022 - $199,223
1,623 Added 0.2%
824,068 $93.3 Million
Q2 2021

Aug 16, 2021
BUY
$83.84 - $104.76 $36,805 - $45,989
439 Added 0.05%
822,445 $85.2 Million
Q1 2021

May 13, 2021
SELL
$78.68 - $90.67 $19,591 - $22,576
-249 Reduced 0.03%
822,006 $68.8 Million
Q4 2020

Feb 12, 2021
SELL
$71.69 - $91.23 $28,891 - $36,765
-403 Reduced 0.05%
822,255 $75 Million
Q3 2020

Nov 12, 2020
SELL
$67.19 - $87.44 $807,086 - $1.05 Million
-12,012 Reduced 1.44%
822,658 $65.7 Million
Q2 2020

Aug 13, 2020
BUY
$57.54 - $76.95 $31.7 Million - $42.4 Million
550,969 Added 194.21%
834,670 $57.7 Million
Q1 2020

May 13, 2020
SELL
$52.41 - $81.0 $584,790 - $903,798
-11,158 Reduced 3.78%
283,701 $53.5 Million
Q4 2019

Feb 14, 2020
BUY
$71.7 - $82.09 $373,198 - $427,278
5,205 Added 1.8%
294,859 $68.8 Million
Q3 2019

Nov 14, 2019
SELL
$61.55 - $75.43 $1.61 Million - $1.97 Million
-26,092 Reduced 8.26%
289,654 $63.7 Million
Q2 2019

Aug 14, 2019
SELL
$55.74 - $64.41 $1.68 Million - $1.94 Million
-30,101 Reduced 8.7%
315,746 $58.3 Million
Q1 2019

May 10, 2019
SELL
$47.89 - $64.05 $488,717 - $653,630
-10,205 Reduced 2.87%
345,847 $66.2 Million
Q4 2018

Feb 13, 2019
SELL
$46.41 - $56.94 $14.5 Million - $17.8 Million
-312,639 Reduced 46.75%
356,052 $18.2 Million
Q3 2018

Nov 13, 2018
SELL
$45.7 - $58.03 $1.78 Million - $2.26 Million
-38,887 Reduced 5.5%
668,691 $116 Million
Q2 2018

Aug 10, 2018
SELL
$42.45 - $51.3 $4.28 Million - $5.17 Million
-100,867 Reduced 12.48%
707,578 $103 Million
Q1 2018

May 09, 2018
SELL
$37.19 - $47.45 $1.19 Million - $1.52 Million
-31,992 Reduced 3.81%
808,445 $113 Million
Q4 2017

Feb 14, 2018
SELL
$33.79 - $39.39 $17,401 - $20,285
-515 Reduced 0.06%
840,437 $0
Q3 2017

Nov 13, 2017
BUY
$36.29 - $38.83 $30.5 Million - $32.7 Million
840,952
840,952 $91.9 Million

Others Institutions Holding EW

# of Institutions
1,383
Shares Held
453M
Call Options Held
6.71M
Put Options Held
3.17M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email